An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With Epilepsy

• Status: Completed
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the long-term retention rate of topiramate in participants with epilepsy (seizure disorder).

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Janssen Korea, Ltd., Korea
• Treatments: Topiramate

Criteria

Inclusion Criteria:

• Participants with all type of epilepsy

• Participants with more than 2 episodes of seizure during last 1 year

• Participants who can comply with the visit schedule and are willing and able to complete evaluation procedures specified in the protocol during the treatment period

• Female participants with child bearing potential and who use proper contraceptive methods during the study period

Exclusion Criteria:

• Participants who have known hypersensitivity reaction or allergy to the study drug

• Participants who have taken topiramate within the three months of study start

• Participants who are determined not to be suitable for the clinical study participation by an Investigator's discretion

• Pregnant and nursing female participants